This inventor holds 2 USPTO granted patents. Top assignee: Dexcel Pharma Technologies Ltd.. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Elisabeth Meimberg: Innovator in Pharmaceutical Compositions
Introduction
Elisabeth Meimberg is a notable inventor based in Emsdetten, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of multiple myeloma. With a total of 2 patents, her work has the potential to impact cancer treatment positively.
Latest Patents
Meimberg's latest patents focus on compositions comprising dexamethasone. One of her key inventions is a pharmaceutical composition that is useful for the treatment of multiple myeloma in combination with an anti-cancer drug. This composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof. This innovative approach aims to enhance the efficacy of cancer treatments.
Career Highlights
Elisabeth Meimberg is associated with Dexcel Pharma Technologies Ltd., where she continues to develop her groundbreaking work. Her expertise in pharmaceutical compositions has positioned her as a valuable asset in the industry.
Collaborations
Meimberg has collaborated with talented individuals such as Corinna Tissen and Tomer Gold. These partnerships have likely contributed to her success and the advancement of her research.
Conclusion
Elisabeth Meimberg's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical science.